Skip to Main Content

National Coverage Analysis (NCA) for Positron Emission Tomography for Initial Treatment Strategy in Solid Tumors and Myeloma (CAG-00181R3)

Expand/collapse the Contacts section

Contact(s)

Jeffrey Roche, MD, MPH

Stuart Caplan, RN, MAS

Stuart.caplan@cms.hhs.gov

410-786-8564

Back to Top

Expand/collapse the Documents section

Documents

Tracking Sheet

Proposed Decision Memo

Decision Memo

View Public Comments

Back to Top

Expand/collapse the History of Considerations section

History of Considerations

Original Consideration for Positron Emission Tomography (FDG) for Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and Testicular Cancers (CAG-00181N)

First reconsideration for Positron Emission Tomography (FDG) for Solid Tumors (CAG-00181R)

Second reconsideration for Positron Emission Tomography (FDG) for Cervical Cancer (CAG-00181R2)

Third reconsideration for Positron Emission Tomography for Initial Treatment Strategy in Solid Tumors and Myeloma (this document)

Fourth reconsideration for Positron Emission Tomography (FDG) for Solid Tumors (CAG-00181R4)

Back to Top

Footer Links

www